00874.HK
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 13.18
+0.53%Margins
Gross margin
15.3%
EBITDA margin
4.8%
EBIT margin
3.7%
Net margin
3.3%
FCF margin
2.8%
6.6%
Return on equity
2.9%
Return on assets
4.9%
Return on invested capital
0.88x
Asset turnover
HKD 4.0B
Cash from operations
HKD 18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026